Structure-function analysis of the active sites of complement receptor type 1

被引:87
作者
Krych, M [1 ]
Hauhart, R [1 ]
Atkinson, JP [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA
关键词
D O I
10.1074/jbc.273.15.8623
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two functionally distinct but homologous sites in complement receptor type 1 (CR1) (CD35) were further characterized by homologous substitution mutagenesis of two CR1 derivatives, each containing one site. In both sites, reducing negative and/or increasing positive charge augmented interaction with iC3/C3b and C4b, supporting a role of ionic forces in the binding reaction. In one case, substitution of Asp at the end of complement control protein repeat (CCP) 2 with an Asn transformed the protein, with negligible cofactor activity and iC3 binding, into a mutant with activities similar to native CR1. Consequently, this protein, one-fourth the size of CRI, is a therapeutic candidate for a complement inhibitor. Another important observation is that the residues between two CCPs contribute to activity, probably because they influence positioning of one CCP relative to the next. The initial characterization of the third CCP of an active site led to identification of three peptides necessary for binding. In line with earlier findings for the first two CCPs, interactions with iC3/C3b are similar but not identical to those with C4b, implying overlapping but distinct binding domains. Moreover, changes in cofactor activity usually, but not always, parallel alterations in binding, indicating that these two activities are separable. We also mapped epitopes for a blocking and a function enhancing monoclonal antibody. Their effects can be explained by epitope location. The first antibody binds near functionally important residues. The second may shield inhibitory (negatively charged) residues. These results represent a comprehensive analysis of the active sites of CR1, which is built of modules found in more than 50 mammalian proteins.
引用
收藏
页码:8623 / 8629
页数:7
相关论文
共 26 条
[1]  
ADAMS EM, 1991, J IMMUNOL, V147, P3005
[2]   SOLUTION STRUCTURE OF A PAIR OF COMPLEMENT MODULES BY NUCLEAR-MAGNETIC-RESONANCE [J].
BARLOW, PN ;
STEINKASSERER, A ;
NORMAN, DG ;
KIEFFER, B ;
WILES, AP ;
SIM, RB ;
CAMPBELL, ID .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (01) :268-284
[3]  
Birmingham DJ, 1996, J IMMUNOL, V157, P2586
[4]   MOLECULAR-CLONING AND CHARACTERIZATION OF THE CDNA CODING FOR C4B-BINDING PROTEIN, A REGULATORY PROTEIN OF THE CLASSICAL PATHWAY OF THE HUMAN-COMPLEMENT SYSTEM [J].
CHUNG, LP ;
BENTLEY, DR ;
REID, KBM .
BIOCHEMICAL JOURNAL, 1985, 230 (01) :133-141
[5]   IDENTIFICATION OF AN ADDITIONAL CLASS OF C3-BINDING MEMBRANE-PROTEINS OF HUMAN PERIPHERAL-BLOOD LEUKOCYTES AND CELL-LINES [J].
COLE, JL ;
HOUSLEY, GA ;
DYKMAN, TR ;
MACDERMOTT, RP ;
ATKINSON, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (03) :859-863
[6]  
COYNE KE, 1992, J IMMUNOL, V149, P2906
[7]   POLYMORPHISM OF HUMAN-ERYTHROCYTE C3B C4B RECEPTOR [J].
DYKMAN, TR ;
COLE, JL ;
IIDA, K ;
ATKINSON, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (06) :1698-1702
[8]   STRUCTURAL HETEROGENEITY OF THE C3B/C4B RECEPTOR (CR-1) ON HUMAN PERIPHERAL-BLOOD CELLS [J].
DYKMAN, TR ;
COLE, JL ;
IIDA, K ;
ATKINSON, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (06) :2160-2165
[9]   IDENTIFICATION OF AN ANTI-MONOCYTE MONOCLONAL-ANTIBODY THAT IS SPECIFIC FOR MEMBRANE COMPLEMENT RECEPTOR TYPE ONE (CR-1) [J].
HOGG, N ;
ROSS, GD ;
JONES, DB ;
SLUSARENKO, M ;
WALPORT, MJ ;
LACHMANN, PJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (03) :236-243
[10]   THE REGULATORS OF COMPLEMENT ACTIVATION (RCA) GENE-CLUSTER [J].
HOURCADE, D ;
HOLERS, VM ;
ATKINSON, JP .
ADVANCES IN IMMUNOLOGY, 1989, 45 :381-416